ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Dr. Lal Path Labs' subsidiary completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, for Rs.38.00 Crore. The target is now a subsidiary.
Dr. Lal PathLabs' subsidiary, DLPL Dubai, completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana. Sunshine Healthcare is now a step-down subsidiary.
Dr. Lal Path Labs Ltd. will acquire a 70% stake in SN Genelab Private Limited for Rs. 168 Crore to strengthen its genomics diagnostics portfolio.
Dr. Lal PathLabs approved the acquisition of a 70% stake in SN Genelab Private Limited for a total consideration of up to ₹199.5 Crore.
Dr. Lal Path Labs Ltd.'s subsidiary completed a 30% stake subscription in Neuome Technologies Private Limited for ₹3.50 Crore, making Neuome an associate company.
Dr. Lal PathLabs' subsidiary, Dr. Lal Ventures, has completed the acquisition of a 30% stake in Neuome Technologies Private Limited.
Dr. Lal Path Labs Ltd.'s subsidiary will acquire a 70% stake in Dr Lal PathLabs Indomed LLC to expand its diagnostics services in Uzbekistan.